We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$107M
1-Year Est. Return
82.62%
This Fund
S&P 500
This Quarter
Est. Return
+19.7%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$16.2M
(+16%)
Cap. Flow
+$781K
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
40.41%
Holding
101
New
3
Increased
31
Reduced
35
Closed
9
Top Buys
| 1 |
Airgain
AIRG
|
+$1.15M |
| 2 |
Digital Turbine
APPS
|
+$1.04M |
| 3 |
Village Farms International
VFF
|
+$762K |
| 4 |
Elutia
ELUT
|
+$707K |
| 5 |
Rockwell Medical
RMTI
|
+$516K |
Top Sells
| 1 |
Perion Network
PERI
|
+$1.05M |
| 2 |
Journey Medical
DERM
|
+$856K |
| 3 |
Perspective Therapeutics
CATX
|
+$555K |
| 4 |
Achieve Life Sciences
ACHV
|
+$538K |
| 5 |
Fortress Biotech
FBIO
|
+$408K |
Sector Composition
| 1 | Healthcare | 50.04% |
| 2 | Technology | 27.4% |
| 3 | Industrials | 10.52% |
| 4 | Communication Services | 6.23% |
| 5 | Consumer Staples | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUGX
1
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $8.57M | 7.32% |
1,464,568
+73,475
| +5% | +$387K |
|
2
Eli Lilly
LLY
$1.05T
| $7.44M | 6.36% |
12,767
-265
| -2% | -$155K |
|
3
Idexx Laboratories
IDXX
$44.8B
| $5.83M | 4.98% |
10,500
-305
| -3% | -$143K |
|
4
Microsoft
MSFT
$2.91T
| $5.76M | 4.92% |
15,326
| – | – |
|
5
Natera
NTRA
$37.9B
| $3.88M | 3.31% |
61,875
-50
| -0.1% | -$2.5K |
|
6
Advanced Micro Devices
AMD
$797B
| $3.41M | 2.91% |
23,104
-130
| -0.6% | -$15.3K |
|
7
Veracyte
VCYT
$4.63B
| $3.22M | 2.75% |
117,180
-2,500
| -2% | -$60.4K |
|
8
NeoGenomics
NEO
$1.9B
| $3.13M | 2.67% |
193,200
-750
| -0.4% | -$12.3K |
|
9
QuickLogic
QUIK
$228M
| $3.08M | 2.64% |
222,606
-3,857
| -2% | -$41.6K |
|
10
Inuvo
INUV
$19.2M
| $2.99M | 2.56% |
704,346
+74,925
| +12% | +$196K |
|
11
Abbott
ABT
$177B
| $2.79M | 2.39% |
25,380
| – | – |
|
12
Alphatec Holdings
ATEC
$1.35B
| $2.79M | 2.39% |
184,867
+12,550
| +7% | +$150K |
|
13
Axogen
AXGN
$2.09B
| $2.05M | 1.75% |
299,615
-1,725
| -0.6% | -$9.59K |
|
|
FPAY
14
DELISTED
FlexShopper
FPAY
| $2.03M | 1.73% |
1,215,793
-49,247
| -4% | -$63.6K |
|
15
LeMaitre Vascular
LMAT
$2.32B
| $2M | 1.71% |
35,301
-135
| -0.4% | -$7.07K |
|
|
CTLP
16
DELISTED
Cantaloupe
CTLP
| $1.94M | 1.65% |
261,100
+750
| +0.3% | +$5.18K |
|
17
Digi International
DGII
$2.38B
| $1.85M | 1.58% |
71,333
+5,300
| +8% | +$132K |
|
|
18
Perion Network
PERI
$371M
| $1.82M | 1.56% |
59,060
-36,875
| -38% | -$1.05M |
|
19
Usio Inc
USIO
$58.5M
| $1.79M | 1.53% |
1,040,693
+35,500
| +4% | +$65K |
|
|
PFIE
20
DELISTED
Profire Energy, Inc
PFIE
| $1.7M | 1.45% |
936,732
+27,652
| +3% | +$52K |
|
|
21
Elutia
ELUT
$39.6M
| $1.68M | 1.44% |
778,502
+431,304
| +124% | +$707K |
|
22
MDxHealth
MDXH
$21.6M
| $1.64M | 1.4% |
415,225
+11,000
| +3% | +$32.9K |
|
23
Ooma
OOMA
$573M
| $1.56M | 1.33% |
145,300
-150
| -0.1% | -$1.7K |
|
24
OptimizeRx
OPRX
$125M
| $1.51M | 1.29% |
105,463
+3,600
| +4% | +$34.5K |
|
25
AbbVie
ABBV
$456B
| $1.42M | 1.21% |
9,158
-1,700
| -16% | -$248K |
|
Similar funds
EWL
ECM
HCA
LLI
CWM
SNPAM
ACL
FMI
Perkins Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Perkins Capital Management held 101 positions worth $117M, up 16% from $101M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Perkins Capital Management's Q4 2023 filing shows 3 new, 31 increased, 35 reduced and 9 closed positions. Its largest new stake was Digital Turbine: 186,200 shares worth $1.28M. The largest sale was Perion Network, an estimated $1.05M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 52% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q4 2023 buy was Digital Turbine: 186,200 shares worth $1.28M.
- Perkins Capital Management added most to Airgain in Q4 2023, an estimated $1.15M increase.
- Perkins Capital Management's biggest Q4 2023 reduction was Perion Network, cutting an estimated $1.05M.
- Perkins Capital Management fully exited Achieve Life Sciences in Q4 2023, selling an estimated $538K.
- Perkins Capital Management's ten largest holdings make up 40% of its $117M portfolio in Q4 2023.
- Perkins Capital Management opened 3 new positions and closed 9 in Q4 2023.
- Perkins Capital Management's portfolio value rose 16% quarter-over-quarter to $117M.
Based on Perkins Capital Management's 13F filing for Q4 2023, filed 22 Jan 2024.